Vivo Capital, LLC Verona Pharma PLC Put Options Transaction History
Vivo Capital, LLC
- $683 Million
- Q3 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding VRNA
# of Institutions
167Shares Held
68.7MCall Options Held
704KPut Options Held
685K-
Perceptive Advisors LLC New York, NY6.32MShares$270 Million4.75% of portfolio
-
Nea Management Company, LLC Timonium, MD5.58MShares$238 Million12.27% of portfolio
-
Ra Capital Management, L.P. Boston, MA5.01MShares$214 Million2.01% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx4.22MShares$180 Million2.52% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.38MShares$144 Million5.24% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $2.6B
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...